{
    "SPADE_N_15453": {
        "Sequence Information": {
            "Peptide Name": "Acremotin C",
            "Sequence": "WXQXITXLXPQXXXXFG",
            "Sequence Length": 17,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Acremonium persicinum SC0105",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Acremotins A-D, peptaibiotics produced by the soil-derived fungus Acremonium persicinum SC0105",
                    "Pubmed ID": "30089870",
                    "Reference": "J Antibiot (Tokyo). 2024;71:927-938",
                    "Author": "Wang C, Wu P, Yao L, Xue J, Xu L, Li H, Deng W, Wei X",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30089870"
                }
            ],
            "SPADE ID": "SPADE_N_15453",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15452",
                    "Similarity": 1.0,
                    "Sequence": "WQITLPQF"
                },
                {
                    "SPADE_ID": "SPADE_N_15454",
                    "Similarity": 1.0,
                    "Sequence": "WQITLPQPFG"
                },
                {
                    "SPADE_ID": "SPADE_UN_10299",
                    "Similarity": 1.0,
                    "Sequence": "NNLLRAIEAQQHLLQLTVWQI"
                }
            ],
            "Hemolytic Activity": "Vero cells:IC50=4.7±0.52 µM",
            "Target Organism": "Staphylococcus aureus ATCC 6538(MIC=12.5µg/ml),Staphylococcus aureus(MIC=25µg/ml),Shigella dysenteriae CMCC 51252(MIC=>100µg/ml),Escherichia coli ATCC 8739(MIC=>100µg/ml),Salmonella typhimurium CMCC 50115(MIC=>100µg/ml),Human lung carcinoma A549(IC50=4.0±0.33µM),Human cervical carcinoma HeLa(IC50=8.0±1.58µM),Human hepatocellular carcinoma HepG2(IC50=1.4±0.15µM)"
        }
    }
}